Description

This study aims to investigate genetic variation associated with Alzheimer’s disease (AD) and AD-related phenotypes, including disease progression, age at onset, and survival. The study includes both whole-genome sequencing (WGS) and genome-wide association study (GWAS) data from individuals of non-Hispanic White ancestry with late-onset Alzheimer’s disease or related phenotypes.

The WGS component was performed using Illumina HiSeq X sequencing to characterize genome-wide variation, including both common and uncommon variants that may contribute to AD risk and disease-related phenotypes. The GWAS component includes approximately 2,440 individuals, comprising AD cases and cognitively normal controls. AD cases met established clinical criteria for probable or definite AD. Samples were genotyped using the Illumina HumanOmni1-Quad BeadChip, providing genome-wide genotype data across approximately one million SNPs. Standard quality-control procedures were applied to the GWAS dataset, with genotype data subsequently imputed using a reference panel. The resulting datasets provide complementary genomic information for investigating genetic factors associated with Alzheimer’s disease and related clinical outcomes.

Principal Investigators

  • Ilyas Kamboh Ph.D. — University of Pittsburgh

Funding Sources

This study is supported by NIH grants R01 AG030653, R01 AG041718, R01 AG064877, and P30 AG066468.

Publications

  • Kamboh MI. Genome-wide association analysis of age-at-onset in Alzheimer's disease. Molecular psychiatry. 2012 Dec. PubMed link
  • Kamboh MI. Genome-wide association study of Alzheimer's disease. Translational psychiatry. 2012 May 15. PubMed link
  • Wang X. Genetic determinants of disease progression in Alzheimer's disease. Journal of Alzheimer's disease : JAD. 2015. PubMed link
  • Fan KH. Whole-Exome Sequencing Analysis of Alzheimer's Disease in Non-APOE*4 Carriers. Journal of Alzheimer's disease : JAD. 2020. PubMed link